JP2025504249A5 - - Google Patents
Info
- Publication number
- JP2025504249A5 JP2025504249A5 JP2024547688A JP2024547688A JP2025504249A5 JP 2025504249 A5 JP2025504249 A5 JP 2025504249A5 JP 2024547688 A JP2024547688 A JP 2024547688A JP 2024547688 A JP2024547688 A JP 2024547688A JP 2025504249 A5 JP2025504249 A5 JP 2025504249A5
- Authority
- JP
- Japan
- Prior art keywords
- liquid formulation
- chelating agent
- serum albumin
- human serum
- botulinum toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22156843 | 2022-02-15 | ||
| EP22156843.9 | 2022-02-15 | ||
| EP22183172 | 2022-07-05 | ||
| EP22183172.0 | 2022-07-05 | ||
| PCT/EP2023/053647 WO2023156389A1 (en) | 2022-02-15 | 2023-02-14 | Liquid botulinum toxin formulation and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504249A JP2025504249A (ja) | 2025-02-06 |
| JP2025504249A5 true JP2025504249A5 (https=) | 2026-01-21 |
Family
ID=85202119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547688A Pending JP2025504249A (ja) | 2022-02-15 | 2023-02-14 | 液体ボツリヌス毒素製剤及びその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250152682A1 (https=) |
| EP (1) | EP4479023A1 (https=) |
| JP (1) | JP2025504249A (https=) |
| KR (1) | KR20240141340A (https=) |
| CN (1) | CN119031902A (https=) |
| AR (1) | AR128514A1 (https=) |
| AU (1) | AU2023221507A1 (https=) |
| CA (1) | CA3243238A1 (https=) |
| CO (1) | CO2024010940A2 (https=) |
| IL (1) | IL315004A (https=) |
| MX (1) | MX2024009970A (https=) |
| TW (1) | TW202348248A (https=) |
| WO (1) | WO2023156389A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025228877A1 (en) | 2024-04-29 | 2025-11-06 | Merz Therapeutics GmbH | Botulinum toxin for the preventive treatment of migraine |
| WO2026021713A1 (en) | 2024-07-23 | 2026-01-29 | Merz Therapeutics GmbH | Uses of magnetic nerve stimulation associated with botulinum neurotoxin administration |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
| US20060269575A1 (en) * | 2000-02-08 | 2006-11-30 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions formulated with recombinant albumin |
| JP2006045173A (ja) * | 2004-08-09 | 2006-02-16 | Hidetoshi Tsuchida | 表面修飾血清アルブミン−金属ポルフィリン複合体、およびそれを含有する酸素輸液 |
| PT2271670E (pt) | 2008-03-14 | 2014-11-28 | Allergan Inc | Ensaio imunobaseado da atividade do serotipo a da toxina botulínica |
| CA2766649C (en) * | 2009-06-24 | 2016-08-23 | Charles N.S. Soparkar | Zinc supplementation to increase responsiveness to metalloprotease therapy |
| ES2653249T3 (es) | 2011-09-29 | 2018-02-06 | Cellsnap, Llc | Composiciones y métodos para ensayos de toxigenicidad |
| AU2014301116B2 (en) | 2013-06-28 | 2019-11-14 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for the determination of the biological activity of Neurotoxin polypeptides in cells |
| PL3463432T3 (pl) * | 2016-05-27 | 2021-04-19 | Ipsen Biopharm Limited | Ciekła formulacja neurotoksyny stabilizowana tryptofanem lub tyrozyną |
-
2023
- 2023-02-14 IL IL315004A patent/IL315004A/en unknown
- 2023-02-14 US US18/838,555 patent/US20250152682A1/en active Pending
- 2023-02-14 WO PCT/EP2023/053647 patent/WO2023156389A1/en not_active Ceased
- 2023-02-14 JP JP2024547688A patent/JP2025504249A/ja active Pending
- 2023-02-14 CA CA3243238A patent/CA3243238A1/en active Pending
- 2023-02-14 KR KR1020247030641A patent/KR20240141340A/ko active Pending
- 2023-02-14 CN CN202380033828.4A patent/CN119031902A/zh active Pending
- 2023-02-14 AU AU2023221507A patent/AU2023221507A1/en active Pending
- 2023-02-14 AR ARP230100336A patent/AR128514A1/es unknown
- 2023-02-14 TW TW112105172A patent/TW202348248A/zh unknown
- 2023-02-14 EP EP23704176.9A patent/EP4479023A1/en active Pending
- 2023-02-14 MX MX2024009970A patent/MX2024009970A/es unknown
-
2024
- 2024-08-12 CO CONC2024/0010940A patent/CO2024010940A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025504249A5 (https=) | ||
| JP2644946B2 (ja) | ＩｇＧ− モノクロナール抗体の精製方法及びその使用方法 | |
| CN113735854B (zh) | 钆和基于非对映异构体富集的pcta的螯合配体的络合物及其制备和纯化方法 | |
| JP2025504247A5 (https=) | ||
| EP0402205B1 (fr) | Procédé de préparation de solutions d'albumine purifiée | |
| JPH07258286A (ja) | ビタミンｋ依存性タンパク質の単離および精製方法 | |
| TW202348248A (zh) | 液體製劑及其製備方法與用途 | |
| KR20050072096A (ko) | 중추신경 기능 개선용 아미노산 조성물 | |
| JPS6042207B2 (ja) | 胎盤よりプラスミノ−ゲン型活性化合物を抽出する方法 | |
| AU730367B2 (en) | Water-soluble peptides | |
| RU2024120804A (ru) | Жидкий состав ботулинического токсина и его применение | |
| JP2942412B2 (ja) | 化粧料 | |
| JPS6042336A (ja) | 免疫グロブリンの製造方法 | |
| KR20240051240A (ko) | 응집체 분리 방법 | |
| JPH07502016A (ja) | 流体からの荷電粒子の単離 | |
| AU642530B2 (en) | A process for treating animal hairs by means of solubilization | |
| CN111067863A (zh) | 一种聚乙二醇修饰的阿加曲班及其长效注射液 | |
| JPS585191A (ja) | カリクレインの精製法 | |
| JP2660484B2 (ja) | ヒト尿性トリプシンインヒビター含有液状製剤 | |
| Hilding et al. | Amino acid composition of human nasal mucus: normal subjects | |
| JPS6317899A (ja) | ハプトグロビンの精製方法 | |
| RU2024120628A (ru) | Жидкий состав ботулинического токсина и его применение | |
| HK40063372B (en) | Complex of gadolinium and a chelating ligand derived from diastereoisomerically enriched pcta and method for preparing and purifying same | |
| Grosser, Y.,* Eales, L.* & Sano | The chemical structure of porphyrin-peptide variegata | |
| CN118055798A (zh) | 改进的纯化方法 |